William Patrick Burke - 03 Jan 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Signature
By: /s/ Kimberly Burke, Attorney in Fact for William Patrick Burke
Issuer symbol
NVCR
Transactions as of
03 Jan 2022
Net transactions value
-$267
Form type
4
Filing time
05 Jan 2022, 15:52:28 UTC
Previous filing
03 Sep 2021
Next filing
12 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $200,000 +17,452 +67% $11.46 43,669 03 Jan 2022 Direct F1
transaction NVCR Ordinary Shares Sale $200,003 -2,633 -6% $75.96 41,036 03 Jan 2022 Direct F1
transaction NVCR Ordinary Shares Options Exercise $69,712 +9,750 +24% $7.15* 50,786 03 Jan 2022 Direct F1
transaction NVCR Ordinary Shares Sale $69,924 -919 -1.8% $76.09 49,867 03 Jan 2022 Direct F2
transaction NVCR Ordinary Shares Options Exercise $30,283 +1,402 +2.8% $21.60 51,269 03 Jan 2022 Direct F1
transaction NVCR Ordinary Shares Sale $30,336 -399 -0.78% $76.03 50,870 03 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -17,452 -100% $0.000000* 0 03 Jan 2022 Ordinary Shares 17,452 $11.46 Direct F3
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -9,750 -100% $0.000000* 0 03 Jan 2022 Ordinary Shares 9,750 $7.15 Direct F3
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1,402 -19% $0.000000 6,098 03 Jan 2022 Ordinary Shares 1,402 $21.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke.
F2 On January 3, 2022, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke, Mr. Burke sold 919 shares in multiple trades at prices ranging from $76.00 to $76.09. The price reported above reflects the weighted average sale price. Mr. Burke hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3 Fully vested as of the date hereof.